MedPath

Huazhong University Of Science And Technology Press Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

213

Active:3
Completed:67

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:8
Phase 2:21
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (140 trials with phase data)• Click on a phase to view related trials

Not Applicable
76 (54.3%)
Phase 2
21 (15.0%)
Phase 4
21 (15.0%)
Phase 3
12 (8.6%)
Phase 1
8 (5.7%)
Early Phase 1
2 (1.4%)

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Phase 4
Recruiting
Conditions
T2DM
Interventions
Drug: SGLT2i+Metformin+Cofrogliptin
Drug: SGLT2i+Metformin+Linagliptin
First Posted Date
2025-06-13
Last Posted Date
2025-06-13
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
170
Registration Number
NCT07019012
Locations
🇨🇳

Wuhan University People's Hospital, Wuhan, Hubei, China

22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions

Not Applicable
Not yet recruiting
Conditions
Abdominal Neoplasm, Excluding Pancreas Neoplasm
Pancreatic Neoplasms
Mediastinal Neoplasms
First Posted Date
2025-06-10
Last Posted Date
2025-07-01
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
576
Registration Number
NCT07012694
Locations
🇨🇳

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health

Not Applicable
Not yet recruiting
Conditions
Cardiopulmonary Function
Environmental Exposures
First Posted Date
2025-06-05
Last Posted Date
2025-06-05
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
600
Registration Number
NCT07005193

Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers

Not Applicable
Not yet recruiting
Conditions
Sleep Disorder
Aging
First Posted Date
2025-05-25
Last Posted Date
2025-05-30
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
80
Registration Number
NCT06990256
Locations
🇨🇳

Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China

Ketamine for Postherpetic Neuralgia With Depression

Phase 4
Not yet recruiting
Conditions
Depression Disorders
Herpetic Neuralgia
Interventions
Drug: Intravenous Ketamine Infusions
Drug: Intravenous normal saline
First Posted Date
2025-05-13
Last Posted Date
2025-06-03
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
50
Registration Number
NCT06968624
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 43
  • Next

News

Neoadjuvant SCRT Plus Camrelizumab Shows Promising 3-Year Survival in Locally Advanced Rectal Cancer

A phase 2 trial demonstrated that neoadjuvant short-course radiotherapy followed by camrelizumab and CAPOX chemotherapy achieved an 80.2% three-year disease-free survival rate in locally advanced rectal cancer patients.

Gene-Edited Pig Kidney Functions in Macaque for Over Six Months in Chinese Study

Chinese scientists achieved a breakthrough by maintaining a gene-edited pig kidney's function in a macaque for 184 days, marking progress in xenotransplantation.

© Copyright 2025. All Rights Reserved by MedPath